Therapeutic Product Immunogenicity Community

 View Only

  • 1.  Immunogenicity Discussion Group: Addressing AAV Vector Immunogenicity in Human

    Community Leadership
    Posted 11-21-2023 12:30

    Hi All,

    On Monday December 11th (12:00 Eastern US, 18:00 Europe) the AAPS Immunogenicity Discussion Group will host a special ad hoc meeting, with Federico Mingozzi joining us to discuss 'Addressing AAV Vector Immunogenicity in Human'

    Federico doesn't need much introduction to this audience, with his contributions to the gene therapy and immunology space over more than two decades…

    If you have team members / colleagues who would like to join the discussion, please let Todd and myself know and we'll get them added to the invitation.

    Thanks

    Rob & Todd

    [email protected]

    [email protected] 



    ------------------------------
    Robert Nelson
    Scientific Officer, Senior Director
    BioAgilytix Europe GmbH
    Hamburg Germany
    [email protected]

    Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer or other entities to which I am affiliated.
    ------------------------------



  • 2.  RE: Immunogenicity Discussion Group: Addressing AAV Vector Immunogenicity in Human

    Community Leadership
    Posted 12-01-2023 09:26

    For those that may have missed it during the Thanksgiving break, a quick reminder to let Todd and I know if you'd like to join this AAPS Immunogenicity Discussion Group call.

    ---

    On Monday December 11th (12:00 Eastern US, 18:00 Europe) the AAPS Immunogenicity Discussion Group will host a special ad hoc meeting, with Federico Mingozzi joining us to discuss 'Addressing AAV Vector Immunogenicity in Human'



    ------------------------------
    Robert Nelson
    Scientific Officer, Senior Director
    BioAgilytix Europe GmbH
    Hamburg Germany
    [email protected]

    Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer or other entities to which I am affiliated.
    ------------------------------

    Original Message


  • 3.  RE: Immunogenicity Discussion Group: Addressing AAV Vector Immunogenicity in Human

    Community Leadership
    Posted 12-07-2023 05:29
      |   view attached

    Hi All,

    A final reminder that on Monday December 11th (12:00 Eastern US, 18:00 Europe) the AAPS Immunogenicity Discussion Group will host a special ad hoc meeting, with Federico Mingozzi joining us to discuss 'Addressing AAV Vector Immunogenicity in Human'

    In case we missed to forward the invite, attached is a calendar invite with connection details...



    ------------------------------
    Robert Nelson
    Scientific Officer, Senior Director
    BioAgilytix Europe GmbH
    Hamburg Germany
    [email protected]

    Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer or other entities to which I am affiliated.
    ------------------------------

    Original Message


  • 4.  RE: Immunogenicity Discussion Group: Addressing AAV Vector Immunogenicity in Human

    Posted 12-08-2023 07:41

    Dear Robert,

    I would like to join the discussion scheduled on 11th Dec. Could you please share the calendar invite?



    ------------------------------
    Sangeetha Makkineni - Senior Research Scientist
    Head of bioanalytical operations
    Syngene International Limited, India
    [email protected]
    +91 9036582542

    Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
    ------------------------------

    Original Message


  • 5.  RE: Immunogenicity Discussion Group: Addressing AAV Vector Immunogenicity in Human

    Posted 12-13-2023 11:46

    Hi Robert,

    I completely missed this announcement. Was the discussion recorded by any chance

    Thanks



    ------------------------------
    C. Elisa Oquendo Cifuentes
    Senior Principal Scientist
    Boehringer Ingelheim Pharmaceuticals Inc
    Ridgefield CT
    [email protected]

    Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
    ------------------------------

    Original Message


  • 6.  RE: Immunogenicity Discussion Group: Addressing AAV Vector Immunogenicity in Human

    Community Leadership
    Posted 12-14-2023 08:02

    Hi All,

    For those unable to join on Monday, we recorded the session and will keep the link open for a few weeks for people to listen in on-demand:

    Federico Mingozzi

    Addressing AAV Vector Immunogenicity in Human

    https://youtu.be/a4LnDfCKglA



    ------------------------------
    Robert Nelson
    Scientific Officer, Senior Director
    BioAgilytix Europe GmbH
    Hamburg Germany
    [email protected]

    Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer or other entities to which I am affiliated.
    ------------------------------

    Original Message